The FDA Approved a New Drug to Prevent Blood Clots [Fortune]
PORTOLA PHARMACEUTICALS (PTLA)
Last portola pharmaceuticals earnings: 2/26 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.portola.com
Company Research
Source: Fortune
The U.S. Food and Drug Administration on Friday approved a new oral blood-thinner made by Portola Pharmaceuticals to prevent deep vein thrombosis and pulmonary embolisms in acutely ill patients who are not undergoing surgery. The drug, BevyxXa, known also as betrixaban, is the first oral treatment and first extended duration treatment for this patient population, the company said. Roughly 200,000 patients in the United States develop deep vein thrombosis each year and about 40,000 of these patients die of pulmonary embolism, caused when a blood clot breaks loose and travels to the lungs, blocking blood flow, the company said. Analysts on average expect the drug to generate sales of $313 million by 2020, rising to more than $1 billion by 2023, according to Thomson Reuters data. Portola's stock was halted at $38.44 pending the news. BevyxXa will compete in the hospital setting with the injectible medications heparin and Sanofi SA's Lovenox, which are typically used for short d
Show less
Read more
Impact Snapshot
Event Time:
PTLA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PTLA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PTLA alerts
High impacting PORTOLA PHARMACEUTICALS news events
Weekly update
A roundup of the hottest topics